The vascularity of the choroid has been implicated in the pathogenesis of various eye diseases. To date, no established quantifiable parameters to estimate vascular status of the choroid exists. Choroidal vascularity index (CVI) may potentially be used to assess vascular status of the choroid. We aimed to establish normative database for CVI and identify factors associated with CVI in healthy eyes. In this population-based study on 345 healthy eyes, choroidal enhanced depth imaging optical coherence tomography scans were segmented by modified image binarization technique. Total subfoveal choroidal area (TCA) was segmented into luminal (LA) and stromal (SA) area. CVI was calculated as the proportion of LA to TCA. Linear regression was used to identify ocular and systemic factors associated with CVI and subfoveal choroidal thickness (SFCT). Subfoveal CVI ranged from 60.07 to 71.27% with a mean value of 65.61 ± 2.33%. CVI was less variable than SFCT (coefficient of variation for CVI was 3.55 vs 40.30 for SFCT). Higher CVI was associated with thicker SFCT, but not associated with most physiological variables. CVI was elucidated as a significant determinant of SFCT. While SFCT was affected by many factors, CVI remained unaffected suggesting CVI to be a more robust marker of choroidal diseases.
The choroid is the vascular layer of eye, with one of the highest blood flow of any tissue in the body1. The choroid is predominantly composed of blood vessels surrounded by stromal tissue comprising of connective tissue, melanocytes, nerves and extracellular fluid2. The vascular layer of the choroid may be differentiated into 3 layers from internal to external, with increasing luminal diameter. The innermost layer is the choriocapillaris, the middle is Sattler’s layer with medium vessels and the outer is Haller’s layer, with large vessels1.
Being a major vascular layer of the eye the choroid plays an important role in ocular health and is involved in the pathogenesis of many intraocular diseases such as age-related macular degeneration, polypoidal choroidal vasculopathy, central serous chorioretinopathy and myopic macular degeneration3,4,5,6,7,8,9. There is evidence from histological studies that the disease processes affect the stroma and vasculature of the choroid10,11,12. However, shrinkage occurs during the fixation of the tissues during the histological process, making it difficult to study the changes in vascular tone of the choroid13.
Choroid thickness (CT) has been reported as an indicator of ocular14,15,16,17 and systemic health18,19,20,21,22. Although, many studies have now reported changes in the thickness of the choroid in various ocular and systemic diseases8,9,10,11,12 and proposed CT as a marker to assess these disease conditions, there exists a notable disparity in CT in various clinical studies. One such example is diabetes mellitus23,24,25,26,27, where there has been no consensus as to whether it causes an increase or decrease in CT. This raises the question of what structures in the choroid changes with increasing or decreasing CT and if there is a more robust marker to assess choroid health.
To answer this question, morphological and vascular analyses of the choroid may provide some clues and lead to the development of a more stable marker. The advent of enhanced depth imaging (EDI) optical coherence tomography (OCT) has allowed more precise non-invasive quantitative assessment of the choroid28. Using EDI OCT, there have been attempts to assess the choroidal stromal and vascular structures13,29,30,31,32. Recently Sonoda et al. described a method for computing luminal and interstitial areas in the choroid as a means to quantify vascular status of the choroid30,31.
Adapting the image segmentation technique proposed by Sonoda et al.30,31, we further propose a new quantitative parameter called choroidal vascularity index (CVI) to assess vascular status of the choroid through image binarization of EDI SD-OCT images in healthy eyes. Furthermore, we aimed to determine the ocular and systemic factors affecting the CVI as well as CT in subjects enrolled from a population-based study in Singapore. This index may provide additional information on the morphology and physiology of the choroid and may be a more robust marker compared to CT.
The data for this study was derived from the Singapore Malay Eye Study-2 (SiMES-2), a population based cohort study of 45–85 years old Malay adults living in Singapore. This study was conducted as per the tenets set forth in the Declaration of Helsinki and ethics committee approval was obtained from the Institutional Review Board of Singapore Eye Research Institute. Written informed consent was obtained from the subjects after explanation about the details of the study and any potential risks involved with the study and consequences of the study.
Details of the study design and methodology have been reported elsewhere33. In this study, we enrolled 400 consecutive participants from February 2012 to April 2013. Exclusion criteria included: logarithmic minimum angle of resolution (logMAR) visual acuity >0.30, spherical equivalent (SE) <−6 diopter, evidence of vitreo-retinal diseases such as age related macular degeneration and diabetic retinopathy, previous ocular surgery or clinical features compatible with a diagnosis of glaucoma and Spectralis OCT imaging with a quality index <18 decibels. Glaucoma was defined using the International Society of Geographic and Epidemiological Ophthalmology scheme34, based on findings from gonioscopy, optic disc characteristics and visual fields results.
Choroidal thickness assessment
The choroid was imaged using the EDI mode of SD-OCT (Spectralis, Heidelberg Engineering, Heidelberg, Germany). The macular region was scanned using a 7 horizontal line scan (30° × 5°) centred on the fovea, with 100 frames averaged in each B-scan. Each scan was 8.9 mm in length and spaced 240 μm apart from each other. In our study, Bruch’s membrane and the choroid-scleral interface were delineated with the automatic segmentation algorithm developed by Tian et al.35 which demonstrated excellent repeatability in our previously reported population-based study36. The choroidal thickness was automatically measured as the distance between the Bruch’s membrane (lower boundary of retinal pigmented epithelium [RPE]) and the choroid-scleral interface. Although measurements of both eyes of each study participant were obtained, due to inter eye correlation only the right eye was used for further analysis.
Image binarization details
The same raster scan passing through the fovea was selected for binarization. It was segmented using the protocol described by Sonoda et al.30,31 with minor modifications. The image binarization was done using public domain software, Image J (version 1.47; http://imagej.nih.gov/ij/). The subfoveal choroidal area with a width of 1.5 mm, centred at the fovea, was selected (Fig. 1A) and this constituted the region of interest. Only 1.5 mm of the macular area on the single line scan was selected as a representative segment of the macular region due to segmental nature of the choroidal blood supply as described by Hayreh37. The posterior ciliary arteries and their branches along with terminal choroidal arterioles, the choriocapillaris and the vortex veins have a segmental or lobular distribution in the choroid.
Image binarization techniques can be used to convert grey scale images into binarized images. This facilitates tasks such as image layout analysis and image skew estimation. An appropriate image binarization technique, taking into account the uneven illumination, image contrast variation and poor image resolution, is essential to accurately apply a threshold to an image. Different image binarization or thresholding techniques like Otsu’s, Bernsen’s and Niblack’s autolocal thresholding techniques were hence attempted38,39. Otsu’s is a global thresholding technique while Bernsen’s is local thresholding technique. After comparing the different image segmentation techniques, we adopted Niblack’s autolocal threshold technique in our current study. This is because it takes into consideration the mean and standard deviation of all the pixels in the region of interest. In addition, given that binarization could be influenced by the variation in the amount of melanin in RPE in different eyes and also affected by the direction of light and focussing issues, these were taken into account by using a distinct binarization threshold for individual subject.
Using Niblack’s autolocal threshold tool, the image was first binarized to get a clear view of the choroid-scleral interface (Fig. 1B). This was to allow more precise selection of the subfoveal choroid area. This is in contrast to Sonoda’s et al.30,31 protocol in which the polygonal area was selected prior to image binarization. In addition, we did not preselect vessels of size more than 100 um.
With the upper border marked at the RPE and the lower border the line of light pixels at the choroid scleral junction, the choroidal area was selected using polygon tool and added to the region of interest manager (Fig. 1B). The image was then converted to RGB (red, green, blue) colour to allow the colour threshold tool to select the dark pixels (Fig. 1C). The total subfoveal circumscribed choroidal area (TCA) and the area of dark pixels were calculated. The luminal area (LA) was defined as the area of dark pixels. Stromal area (SA) was further calculated by subtracting LA from TCA. To determine the vascularity status of the choroid, CVI was computed by dividing LA by TCA. In addition, the proportion of dark (LA) to light areas (SA) was also computed. Fig. 1D represents the overlay image of the region on interest on the original EDI OCT scan.
Inter-rater and Intra-rater agreement
10% of the total images (35 images), were initially segmented by two graders (KAT and RA) to determine inter-rater agreement. The same set of images was segmented by one grader (KAT) after an interval of one week to compute intra-rater reliability. The intra- and inter-rater reliability for the image binarization was measured by the absolute agreement model of the intra-class correlation coefficient (ICC)40. ICC value of 0.81–1.00 indicates good agreement. Values of less than 0.40 indicate poor to fair agreement. We also performed Bland-Altman plot analyses41,42 to determine the mean difference between the measurements. The Bland-Altman plots were constructed using MedCalc version 12.3 (Medcalc Software, Ostend, Belgium) software. Moreover, random scans, including those with thick and thin choroid, were further reviewed by both graders to ensure good inter-rater agreement. After obtaining good inter-rater and intra-rater agreement, all the scans were binarized by single author (KAT).
Measurement of ocular factors
Each participant underwent a standardized examination. Refraction and corneal curvature were measured using an auto-keratorefractor (Canon RK 5 Auto Ref-Keratometer, Canon Inc. Ltd., Tochigiken, Japan). SE was calculated as the sum of the spherical power and half of the cylinder power. Best-corrected visual acuity was measured monocularly using a LogMAR chart (Lighthouse International, New York, USA) at a distance of 4 meters. Ocular biometry, including axial length (AL), was measured using non-contact partial coherence interferometry (IOL Master V3.01, Carl Zeiss Meditec AG, Jena, Germany). Intraocular pressure (IOP) was measured using Goldmann applanation tonometry (Haag-Streit, Bern, Switzerland) before pupil dilation. Standardized visual field testing was performed with static automated white-on-white threshold perimetry (SITA Fast 24-2, Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc., Oberkochen, Germany). Slit-lamp biomicroscopy (Haag-Streit model BQ-900; Haag-Streit, Switzerland) was performed by the study ophthalmologists to examine the anterior chamber and lens after pupil dilation with tropicamide 1% and phenylephrine hydrochloride 2.5%.
Measurement of systemic factors
A detailed interviewer-administered questionnaire was used to collect demographic data, lifestyle risk factors (e.g. smoking, alcohol consumption), medical history (e.g. hypertension, diabetes), ocular history (e.g. glaucoma) and medication use from all participants. Systolic and diastolic blood pressures (BP) were measured using a digital automatic blood pressure monitor (Dinamap model Pro Series DP110X-RW, 100V2; GE Medical Systems Information Technologies, Inc., Milwaukee, WI), after subjects were seated for at least five minutes. BP was measured twice, with measurements 5 minutes apart. A third measurement was taken if the previous 2 systolic BP readings differed by more than 10 mmHg or the diastolic BP differed by more than 5 mmHg. The mean of the two closest BP readings was taken as each participant’s BP.
Mean ocular perfusion pressure (OPP) was calculated using the following equation: mean OPP = (2/3 × mean arterial pressure [MAP] – IOP), where MAP = diastolic BP + (1/3 × [systolic BP – diastolic BP]). Body mass index (BMI) was calculated as body weight (in kilograms) divided by body height (in meters) squared. Smoking status was defined as those currently smoking, ex-smokers and non-smokers. Nonfasting venous blood samples were analysed at the National University Hospital Reference Laboratory for biochemical testing of serum total cholesterol, triglycerides, glycosylated haemoglobin (HbA1c), serum glucose level and creatinine.
Statistical analysis was performed using SPSS version 20.0 (SPSS, Inc., Chicago, IL, USA). Since CVI and subfoveal choroidal thickness (SFCT) have different measurement units, we used the coefficient of variation (COV) to compare the variability between CVI and SFCT. Univariate and multiple linear regression analyses were performed to determine the associations of SFCT and CVI (dependent variables) with ocular and systemic factors (independent variables). For multiple linear regression, factors showing significant association in univariate analysis (p < 0.10) were included. All p values were 2-sided and considered statistically significant when the values were less than 0.05.
A total of 400 subjects were recruited for this study. We excluded 55 subjects for the following reasons: visual acuity worse than 0.30 (n = 9), SE < −6 diopter (n = 7), glaucoma (n = 6), presence of macular or vitreo-retinal diseases (n = 18) and poor OCT image quality (n = 15). A total of 345 eyes from 345 subjects were included in the final analysis; 190 (55%) subjects were female. The demographics, ocular, systemic and choroidal characteristics of the study subjects are shown in Table 1. In terms of choroidal characteristics, mean TCA was 0.74 ± 0.21 mm2 and mean LA was 0.49 ± 0.15 mm2. Mean SFCT was 241.34 ± 97.11 μm (range, 40.24–519.48 μm) and mean CVI was 65.61 ± 2.33% (range, 60.07–71.27%).
CVI was found to have lower COV (3.55) than SFCT (COV = 40.30), indicating CVI to be less variable than SFCT. The histogram plots (Fig. 2A,B) represent the distribution of SFCT and CVI in relation to normal density plot.
Using image binarization, the intra- (ICC: 0.97 to 0.99 for TCA and ICC: 0.91 to 0.98 for LA) and inter-grader reliability (ICC: 0.90 to 0.97 for TCA and ICC: 0.89 to 0.97 for LA) were excellent for both TCA and LA (Table 2). Bland Altman plot analysis of intra- and inter-rater reliability for TCA (Fig. 3A,B) and LA (Fig. 3C,D) at sub-foveal location was excellent.
In Table 3, the multiple regression model shows younger age, shorter AL, higher IOP, higher LA and lower systolic blood pressure to be significantly (p < 0.05) associated with thicker sub-foveal choroid. However, among factors associated with CVI (Table 4), in the multiple regression model, SFCT was the only factor associated with CVI. A thicker sub-foveal choroid was significantly (p < 0.001) associated with higher CVI. There were no other statistically significant association between CVI and any other factors (Table 4).
In this population-based study, using the modified Sonoda’s image binarization technique for EDI SD-OCT scans, we propose an OCT based metric termed “CVI” to assess vascularity of the choroid. Our results validated the findings obtained by Sonoda et al. and found that on a single cross sectional scan, nearly two third (~66%) of the subfoveal choroid is vascular in healthy eyes. Importantly, CVI showed lesser variability and was influenced by fewer physiologic factors as opposed to CT, indicating CVI to be a relatively stable index for studying the changes in the choroid. As the choroid is primarily a vascular structure, understanding of this new vascular index may help to further elucidate the role of vascular processes within the choroid in disease development and progression. We hence propose CVI as an independent surrogate marker to assess choroidal health in future studies.
Several studies have assessed the vascular structures of the choroid by OCT13,29, but they required customized software that limited their widespread use. There are reports30,31 on the differentiation and quantification of the structural components of the choroid (luminal and interstitial areas), using freely and easily accessible software, Image J, these studies were performed in clinic-based settings with a potential selection and sampling biases. We have highlighted the significant differences in our protocol with that proposed by Sonoda et al.30,31 in Table 5. Our modification of applying auto local threshold prior to image binarization enabled us to accurately localise choroid scleral interface giving more precise selection of the choroid. In addition, the simple binarization technique without pre-selection of larger choroidal vessels allowed nearly accurate estimation of vascularity of the choroid even with a very simple algorithm, which can be reproduced by the large research community.
Although there is no concrete evidence that the dark areas represented the vascular areas and the light areas the stromal areas, the findings of earlier studies and that of numerous empirical observations suggest that the dark areas were the vascular components in the binarized images13,29. In addition, a comparison of the original EDI-OCT images to the binary images (Fig. 1) revealed that the dark areas corresponded with vascular components of the choroid, including both the larger and smaller choroidal vessels. Therefore, the binarization technique developed by Sonoda et al.30,31, which was further simplified by us, is valid and offers precise segmentation of choroidal vasculature from stroma.
Interestingly, when comparing the factors affecting SFCT to those that affect CVI, we found SFCT to be associated with many physiological factors such as age, AL, IOP and, most significantly, the vascular area in the choroid (LA), whereas stromal area did not have a significant association with SFCT. On the other hand, CVI was only affected by SFCT, but was not affected by most of the physiological variables. Moreover, SFCT demonstrated relatively greater variability (mean SFCT was 241.34 ± 97.11 μm, COV = 40.30) compared to CVI (mean CVI was 65.61 ± 2.33%, COV = 3.55). Thus our results suggest CVI to be a better and relatively more stable marker to monitor choroid compared to CT, which is affected by more variables and demonstrated greater variability. Clinically, measuring the proportion of vascularity of the eye would provide us with a deeper understanding of how disease processes affect different structures in the eye and therefore may be more informative compared to CT measurements alone.
We have demonstrated a significant association of SFCT with vascular area of the choroid. This signifies the fact that the vascular area is the predominant segment influencing the CT in normal population. An increase in CVI reflects either an increase in the number of blood vessels or in the diameter of the choroidal blood vessels within a designated area. Hayreh37 demonstrated the vulnerability of submacular choroidal supply to generalised chronic ischaemic disorders (age related macular degeneration), due to numerous watershed zones of the short posterior ciliary arteries in the choroid. There can be potential clinical implications of the CVI, which can be explored in further studies. A decrease in CVI on EDI OCT scans at baseline may be an indicator of choroidal ischemia in patients with macular disorders like age related macular degeneration or diabetes. On the other hand, we may use CVI to determine increase in vascularity of the choroid in posterior uveitis or central serous chorioretinopathy. CVI can also be used as a follow up tool for treatment response and resolution of diseases.
The strengths of our study include a large sample size with a single common ethnicity. Hence, our findings were unlikely to be confounded by ethnic heterogeneity. Standardized clinical examination protocols, as well as reliable differentiation and quantifications of choroidal morphometric parameters and OCT parameters were used in our study. Nevertheless, this study has few limitations. First, binarization of choroidal images was performed only in the right eye of each study subject. There may exist inter-eye differences, yet such differences should be small. Second, the CT measurements in our study were not performed at the same time of the day; each participant underwent the OCT examination in a randomized manner with respect to when the readings were obtained. It seems unlikely that circadian changes may have influenced the results of our investigation. Third, although our images were binarized at standard threshold, there is a possibility of over or underestimation of both SA and LA.
In conclusion, in this population-based study, we introduced a novel OCT based marker termed “CVI” to assess vascularity of the subfoveal choroid. Our result showed that on a single cross sectional EDI-OCT image, two-third (~66%) of the subfoveal choroid is vascular in healthy eyes. This index should provide a new means of studying the pathophysiology of human choroid in greater detail. However, larger studies for different disease models are warranted to further validate the application of this index in clinical practice. Whether CVI is a complimentary or substitute tool to CT can only be answered based on the proposed studies in choroidal diseases.
How to cite this article: Agrawal, R. et al. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci. Rep. 6, 21090; doi: 10.1038/srep21090 (2016).
Alm, A. & Bill, A. Ocular and optic nerve blood flow at normal and increased intraocular pressures in monkeys (Macaca irus): a study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Exp Eye Res 15, 15–29 (1973).
Nickla, D. L. & Wallman, J. The multifunctional choroid. Prog Retin Eye Res 29, 144–168 (2010).
Chung, S. E., Kang, S. W., Lee, J. H. & Kim, Y. T. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 118, 840–845 (2011).
Fujiwara, T., Imamura, Y., Margolis, R., Slakter, J. S. & Spaide, R. F. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 148, 445–450 (2009).
Gomi, F. & Tano, Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 19, 208–212 (2008).
Grossniklaus, H. E. & Green, W. R. Choroidal neovascularization. Am J Ophthalmol 137, 496–503 (2004).
Gupta, B. & Mohamed, M. D. Photodynamic therapy for variant central serous chorioretinopathy: efficacy and side effects. Ophthalmologica 225, 207–210 (2011).
Ikuno, Y. & Tano, Y. Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 50, 3876–3880 (2009).
Koizumi, H., Yamagishi, T., Yamazaki, T., Kawasaki, R. & Kinoshita, S. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 249, 1123–1128 (2011).
Lutty, G. A., Cao, J. & McLeod, D. S. Relationship of polymorphonuclear leukocytes to capillary dropout in the human diabetic choroid. Am J Pathol 151, 707–714 (1997).
Fryczkowski, A. W., Sato, S. E. & Hodes, B. L. Changes in the diabetic choroidal vasculature: scanning electron microscopy findings. Ann Ophthalmol 20, 299–305 (1988).
Sakamoto, T., Murata, T. & Inomata, H. Class II major histocompatibility complex on melanocytes of Vogt-Koyanagi-Harada disease. Arch Ophthalmol 109, 1270–1274 (1991).
Branchini, L. A. et al. Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography. Ophthalmology 120, 1901–1908 (2013).
Lindner, M. et al. Choroidal thickness in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 56, 875–882 (2015).
Young, M., Fallah, N. & Forooghian, F. Choroidal degeneration in birdshot chorioretinopathy. Retina 35, 798–802 (2015).
Tseng, C. C. & Chen, S. N. Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy. Br J Ophthalmol 99, 1070–1077(2015).
Gupta, P. et al. Choroidal thickness and high myopia: a case-control study of young Chinese men in Singapore. Acta ophthalmol, doi: 10.1111/aos12631 (2014).
Kim, J. T., Lee, D. H., Joe, S. G., Kim, J. G. & Yoon, Y. H. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. Invest Ophthalmol Vis Sci 54, 3378–3384 (2013).
Wong, I. Y., Wong, R. L., Zhao, P. & Lai, W. W. Choroidal thickness in relation to hypercholesterolemia on enhanced depth imaging optical coherence tomography. Retina 33, 423–428 (2013).
Ahn, S. J., Woo, S. J. & Park, K. H. Retinal and choroidal changes with severe hypertension and their association with visual outcome. Invest Ophthalmol Vis Sci 55, 7775–7785 (2014).
Sizmaz, S. et al. The effect of smoking on choroidal thickness measured by optical coherence tomography. Br J Ophthalmol 97, 601–604 (2013).
Takahashi, H. et al. Choroidal thickness in convalescent vogt-koyanagi-harada disease. Retina 34, 775–780 (2014).
Lee, H. K., Lim, J. W. & Shin, M. C. Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography. Korean J Ophthalmol 27, 433–439 (2013).
Unsal, E. et al. Choroidal thickness in patients with diabetic retinopathy. Clin Ophthalmol 8, 637–642, (2014).
Gerendas, B. S. et al. Three-dimensional automated choroidal volume assessment on standard spectral-domain optical coherence tomography and correlation with the level of diabetic macular edema. Am J Ophthalmol 158, 1039–1048 (2014).
Adhi, M., Brewer, E., Waheed, N. K. & Duker, J. S. Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography. JAMA Ophthalmol 131, 1267–1274 (2013).
Farias, L. B. et al. Choroidal thickness in patients with diabetes and microalbuminuria. Ophthalmology 121, 2071–2073 (2014).
Spaide, R. F., Koizumi, H. & Pozzoni, M. C. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 146, 496–500 (2008).
Sohrab, M., Wu, K. & Fawzi, A. A. A pilot study of morphometric analysis of choroidal vasculature in vivo, using en face optical coherence tomography. PLoS One 7, doi: 10.1371/journal.pone.0048631 (2012).
Sonoda, S. et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci 55, 3893–3899 (2014).
Sonoda, S. et al. Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images. Am J Ophthalmol 159, 1123–1131 (2015).
Iwata, A. et al. Binarization of enhanced depth imaging optical coherence tomographic images of an eye with Wyburn-Mason syndrome: a case report. BMC Ophthalmol 15, (2015).
Foong, A. W. et al. Rationale and methodology for a population-based study of eye diseases in Malay people: The Singapore Malay eye study (SiMES). Ophthalmic Epidemiol 14, 25–35 (2007).
Foster, P. J., Buhrmann, R., Quigley, H. A. & Johnson, G. J. The definition and classification of glaucoma in prevalence surveys. Br J Ophthalmol 86, 238–242 (2002).
Tian, J., Marziliano, P., Baskaran, M., Tun, T. A. & Aung, T. Automatic segmentation of the choroid in enhanced depth imaging optical coherence tomography images. Biomed Opt Express 4, 397–411 (2013).
Gupta, P. et al. Distribution and determinants of choroidal thickness and volume using automated segmentation software in a population-based study. Am J Ophthalmol 159, 293–301 (2015).
Hayreh, S. S. Segmental nature of the choroidal vasculature. Br J Ophthalmol 59, 631–648 (1975).
Bernsen, J. Dynamic thresholding of grey-level images. Eighth International Conference of Pattern Recognition, France. Paris: Conference proceedings. doi: 10.5120/18107-9291 (1986 Oct).
Niblack, W. In An Introduction to Digital Image Processing. (Prentice Hall International Inc., 1986).
Fleiss, J. L. & Cohen, J. The Equivalence of Weighted Kappa and the Intraclass Correlation Coefficient as Measures of Reliability. Educational and Psychological Measurement 33, 613–619 (1973).
Bland, J. M. & Altman, D. G. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986).
Bland, J. M. & Altman, D. G. Agreed statistics: measurement method comparison. Anesthesiology 116, 182–185 (2012).
This study was supported by a grant from National Medical Research Council, Singapore [Grant No. NMRC R760/44/2010]. The funding organization had no role in the design or conduct of this research.
The authors declare no competing financial interests.
About this article
Cite this article
Agrawal, R., Gupta, P., Tan, K. et al. Choroidal vascularity index as a measure of vascular status of the choroid: Measurements in healthy eyes from a population-based study. Sci Rep 6, 21090 (2016). https://doi.org/10.1038/srep21090
Use of choroidal vascularity index for choroidal structural evaluation in smokers: an optical coherence tomography study
Cutaneous and Ocular Toxicology (2020)
Scientific Reports (2020)
Choroidal Vascularity Index: An In-Depth Analysis of This Novel Optical Coherence Tomography Parameter
Journal of Clinical Medicine (2020)
Acta Ophthalmologica (2020)
Choroidal vascularity index determined by binarization of enhanced depth imaging optical coherence tomography images in eyes with intermediate age-related macular degeneration
European Journal of Ophthalmology (2020)